TransMedics Group (TMDX)
(Delayed Data from NSDQ)
$120.55 USD
+1.58 (1.33%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $120.51 -0.04 (-0.03%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TMDX 120.55 +1.58(1.33%)
Will TMDX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TMDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TMDX
TMDX Stock Gains Post Q2 Earnings & Revenue Beat, Margins Up
TransMedics (TMDX) Reports Q2 Earnings: What Key Metrics Have to Say
TMDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
TransMedics (TMDX) Q2 Earnings and Revenues Surpass Estimates
Countdown to TransMedics (TMDX) Q2 Earnings: Wall Street Forecasts for Key Metrics
Veracyte (VCYT) Soars 7.0%: Is Further Upside Left in the Stock?
Other News for TMDX
Morgan Stanley Raises Price Target for TMDX to $123 | TMDX Stock News
What TransMedics Just Taught Me About Trusting The Algorithm
TransMedics: Continued Strength Suggests Further Upside
TransMedics Group Inc (TMDX) Announces Inducement Grants to New Employees | TMDX stock news
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | TMDX Stock News